Zebra Capital Management’s Astrana Health ASTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-6,194
| Closed | -$239K | – | 122 |
|
|
2022
Q2 | $239K | Buy |
6,194
+463
| +8% | +$17.9K | 0.7% | 61 |
|
|
2022
Q1 | $278K | Buy |
5,731
+138
| +2% | +$6.69K | 0.64% | 62 |
|
|
2021
Q4 | $411K | Buy |
5,593
+271
| +5% | +$19.9K | 0.66% | 51 |
|
|
2021
Q3 | $485K | Hold |
5,322
| – | – | 0.59% | 51 |
|
|
2021
Q2 | $334K | Buy |
+5,322
| New | +$334K | 0.39% | 98 |
|
|
2020
Q3 | – | Sell |
-18,356
| Closed | -$303K | – | 288 |
|
|
2020
Q2 | $303K | Sell |
18,356
-430
| -2% | -$7.1K | 0.44% | 88 |
|
|
2020
Q1 | $243K | Buy |
18,786
+2,894
| +18% | +$37.4K | 0.39% | 110 |
|
|
2019
Q4 | $293K | Buy |
+15,892
| New | +$293K | 0.26% | 166 |
|